These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8683692)

  • 1. Transurethral needle ablation of the prostate: report of initial United States clinical trial.
    Issa MM
    J Urol; 1996 Aug; 156(2 Pt 1):413-9. PubMed ID: 8683692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
    Bruskewitz R; Issa MM; Roehrborn CG; Naslund MJ; Perez-Marrero R; Shumaker BP; Oesterling JE
    J Urol; 1998 May; 159(5):1588-93; discussion 1593-4. PubMed ID: 9554360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study.
    Roehrborn CG; Burkhard FC; Bruskewitz RC; Issa MM; Perez-Marrero R; Naslund MJ; Shumaker BP
    J Urol; 1999 Jul; 162(1):92-7. PubMed ID: 10379748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open study on the efficacy and safety of transurethral needle ablation of the prostate in treating symptomatic benign prostatic hyperplasia: the University of Florida experience.
    Kahn SA; Alphonse P; Tewari A; Narayan P
    J Urol; 1998 Nov; 160(5):1695-700. PubMed ID: 9783934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of transperineal prostatic block for transurethral needle ablation for benign prostatic hyperplasia: the Emory University Experience.
    Issa MM; Perez-Brayfield M; Petros JA; Anastasia K; Labadia AJ; Miller LE
    J Urol; 1999 Nov; 162(5):1636-9. PubMed ID: 10524886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized study comparing visual laser ablation and transurethral evaporation of prostate in the management of benign prostatic hyperplasia.
    Narayan P; Tewari A; Aboseif S; Evans C
    J Urol; 1995 Dec; 154(6):2083-8. PubMed ID: 7500464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives.
    Schatzl G; Madersbacher S; Lang T; Marberger M
    J Urol; 1997 Jul; 158(1):105-10; discussion 110-1. PubMed ID: 9186334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: a neurohistochemical study.
    Zlotta AR; Raviv G; Peny MO; Noel JC; Haot J; Schulman CC
    J Urol; 1997 Mar; 157(3):894-9. PubMed ID: 9072594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation.
    Grise P; Plante M; Palmer J; Martinez-Sagarra J; Hernandez C; Schettini M; Gonzalez-Martin M; Castiñeiras J; Ballanger P; Teillac P; Rolo F; Baena V; Erdmann J; Mirone V
    Eur Urol; 2004 Oct; 46(4):496-501; discussion 501-2. PubMed ID: 15363567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
    Rosario DJ; Phillips JT; Chapple CR
    J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transurethral needle ablation of the prostate: a urodynamic based study with 2-year followup.
    Steele GS; Sleep DJ
    J Urol; 1997 Nov; 158(5):1834-8. PubMed ID: 9334612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Office based transurethral needle ablation of the prostate with analgesia and local anesthesia.
    Leocádio DE; Frenkl TL; Stein BS
    J Urol; 2007 Nov; 178(5):2052-4; discussion 2054. PubMed ID: 17869294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: The CLasP study.
    Gujral S; Abrams P; Donovan JL; Neal DE; Brookes ST; Chacko KN; Wright MJ; Timoney AG; Peters TJ
    J Urol; 2000 Jul; 164(1):59-64. PubMed ID: 10840425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/II examination of transurethral ethanol ablation of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
    Plante MK; Marks LS; Anderson R; Amling C; Rukstalis D; Badlani G; Getlin L; Vang E
    J Urol; 2007 Mar; 177(3):1030-5; discussion 1035. PubMed ID: 17296405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of the safety and efficacy of suprapubic transvesical prostatectomy in patients with benign prostatic hyperplasia.
    Tubaro A; Carter S; Hind A; Vicentini C; Miano L
    J Urol; 2001 Jul; 166(1):172-6. PubMed ID: 11435849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transurethral needle ablation (TUNA): histopathological, radiological and clinical studies of a new office procedure for treatment of benign prostatic hyperplasia.
    Schulman CC; Zlotta AR
    Prog Clin Biol Res; 1994; 386():479-86. PubMed ID: 7528418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Holmium laser versus transurethral resection of the prostate: a randomized prospective trial with 1-year followup.
    Gilling PJ; Mackey M; Cresswell M; Kennett K; Kabalin JN; Fraundorfer MR
    J Urol; 1999 Nov; 162(5):1640-4. PubMed ID: 10524887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photoselective vaporization of the prostate in the treatment of benign prostatic hyperplasia.
    Fu WJ; Hong BF; Yang Y; Cai W; Gao JP; Wang CY; Wang XX
    Chin Med J (Engl); 2005 Oct; 118(19):1610-4. PubMed ID: 16232345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transurethral microwave therapy in 200 patients with a minimum followup of 2 years: urodynamic and clinical results.
    Thalmann GN; Mattei A; Treuthardt C; Burkhard FC; Studer UE
    J Urol; 2002 Jun; 167(6):2496-501. PubMed ID: 11992066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel transurethral microwave thermal ablation system to treat benign prostatic hyperplasia: results of a prospective multicenter clinical trial.
    Ramsey EW; Miller PD; Parsons K
    J Urol; 1997 Jul; 158(1):112-8; discussion 118-9. PubMed ID: 9186335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.